News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hearne Michael S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 185 shares
@ $3.468, valued at
$641.6
Granted 185 options to buy
@ $4.08, valued at
$754.8 |
|
| 04/18/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 173 shares
@ $3.7145, valued at
$642.6
Granted 173 options to buy
@ $4.37, valued at
$756 |
|
| 04/04/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 177 shares
@ $3.6295, valued at
$642.4
Granted 177 options to buy
@ $4.27, valued at
$755.8 |
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 169 shares
@ $3.791, valued at
$640.7
Granted 169 options to buy
@ $4.46, valued at
$753.7 |
|
| 02/02/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 1,675 shares
@ $3.9355, valued at
$6.6k
Granted 1,675 options to buy
@ $4.63, valued at
$7.8k
|
|
| 01/19/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 148 shares
@ $4.182, valued at
$618.9
Granted 148 options to buy
@ $4.92, valued at
$728.2 |
|
| 01/14/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 78,552 options to buy
@ $4.81, valued at
$377.8k
|
|
| 01/04/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 157 shares
@ $3.9185, valued at
$615.2
Granted 157 options to buy
@ $4.61, valued at
$723.8 |
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Sold 193,403 shares
@ $4.1008, valued at
$793.1k
Sold 6,597 shares
@ $3.9514, valued at
$26.1k
Sold 63,745 shares
@ $3.9461, valued at
$251.5k
Sold 136,255 shares
@ $3.7586, valued at
$512.1k
Sold 41,290 shares
@ $3.6644, valued at
$151.3k
|
|
| 11/19/2021 |
4
| TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Sold 468,849 shares
@ $2.6583, valued at
$1.2M
Sold 31,151 shares
@ $1.9941, valued at
$62.1k
Sold 500,000 shares
@ $2.0161, valued at
$1M
Sold 287,577 shares
@ $2.1985, valued at
$632.2k
Sold 212,423 shares
@ $1.9708, valued at
$418.6k
Sold 500,000 shares
@ $1.8812, valued at
$940.6k
Sold 381,842 shares
@ $1.8925, valued at
$722.6k
Sold 365,289 shares
@ $1.9161, valued at
$699.9k
|
|
| 11/17/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 181 shares
@ $3.4085, valued at
$616.9
Granted 181 options to buy
@ $4.01, valued at
$725.8 |
|
| 11/02/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 181 shares
@ $3.417, valued at
$618.5
Granted 181 options to buy
@ $4.02, valued at
$727.6 |
|
| 10/19/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 183 shares
@ $3.366, valued at
$616
Granted 183 options to buy
@ $3.96, valued at
$724.7 |
|
| 10/04/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 182 shares
@ $3.3915, valued at
$617.3
Granted 182 options to buy
@ $3.99, valued at
$726.2 |
|
| 09/17/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 546 shares
@ $3.3915, valued at
$1.9k
Granted 546 options to buy
@ $3.99, valued at
$2.2k
|
|
| 08/03/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 201 shares
@ $3.0685, valued at
$616.8
Granted 201 options to buy
@ $3.61, valued at
$725.6 |
|
| 07/19/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 193 shares
@ $3.196, valued at
$616.8
Granted 193 options to buy
@ $3.76, valued at
$725.7 |
|
| 07/02/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 170 shares
@ $3.638, valued at
$618.5
Granted 170 options to buy
@ $4.28, valued at
$727.6 |
|
| 06/17/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 148 shares
@ $4.165, valued at
$616.4
Granted 148 options to buy
@ $4.9, valued at
$725.2 |
|
| 06/02/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 169 shares
@ $3.655, valued at
$617.7
Granted 169 options to buy
@ $4.3, valued at
$726.7 |
|
| 06/01/2021 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Bought 1,286 shares
@ $4.4984, valued at
$5.8k
Bought 184,642 shares
@ $4.4734, valued at
$826k
Bought 15,358 shares
@ $4.292, valued at
$65.9k
Bought 43,734 shares
@ $4.5277, valued at
$198k
|
|
| 05/26/2021 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Bought 104,403 shares
@ $3.6803, valued at
$384.2k
Bought 95,597 shares
@ $3.7748, valued at
$360.9k
Bought 31,782 shares
@ $3.8347, valued at
$121.9k
Bought 166,932 shares
@ $4.2578, valued at
$710.8k
|
|
| 05/18/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 193 shares
@ $3.196, valued at
$616.8
Granted 193 options to buy
@ $3.76, valued at
$725.7 |
|
|
|
|